The genetic defect of mdx mice resembles that of Duchenne muscular dystrophy, although their functional performance and life expectancy is nearly normal. By contrast, mice lacking utrophin and dystrophin (mdx/utrn -/-) are severely affected and die prematurely. Mice with one utrophin allele (mdx/utrn +/-) are more severely affected than mdx mice, but outlive mdx/utrn -/- mice. We subjected mdx/utrn +/+, +/-, -/- and wild type males to a 12week functional test regime of four different functional tests. Mdx/utrn +/+ and +/- mice completed the regime, while mdx/utrn -/- mice died prematurely. Mdx/utrn +/- mice performed significantly worse compared to mdx/utrn +/+ mice in functional tests. Creatine kinase levels, percentage of fibrotic/necrotic tissue, morphology of neuromuscular synapses and expression of biomarker genes were comparable, whereas mdx/utrn +/- and -/- mice had increased levels of regenerating fibers. This makes mdx/utrn +/- mice valuable for testing the benefit of potential therapies on muscle function parameters.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.nmd.2011.10.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Angiopoietin 1 Attenuates Dysregulated Angiogenesis in the Gastrocnemius of DMD Mice.
Int J Mol Sci
November 2024
Department of Medical Biophysics, Western University, London, ON N6A 5C1, Canada.
Duchenne muscular dystrophy (DMD) is a degenerative neuromuscular disease caused by a lack of functional dystrophin. Ang 1 paracrine signalling maintains the endothelial barrier of blood vessels, preventing plasma leakage. Chronic inflammation, a consequence of DMD, causes endothelial barrier dysfunction in skeletal muscle.
View Article and Find Full Text PDFInhibition of miR-25 ameliorates cardiac and skeletal muscle dysfunction in aged haploinsufficient (+/-) mice.
Mol Ther Nucleic Acids
June 2024
Department of Medicinal and Life Science, College of Science and Convergence Technology, Hanyang University-ERICA, Ansan, South Korea.
Dystrophic cardiomyopathy is a significant feature of Duchenne muscular dystrophy (DMD). Increased cardiomyocyte cytosolic calcium (Ca) and interstitial fibrosis are major pathophysiological hallmarks that ultimately result in cardiac dysfunction. MicroRNA-25 (miR-25) has been identified as a suppressor of both sarcoplasmic reticulum calcium ATPase 2a (SERCA2a) and mothers against decapentaplegic homolog-7 (Smad7) proteins.
View Article and Find Full Text PDFImproved mitochondrial function in the hearts of sarcolipin-deficient dystrophin and utrophin double-knockout mice.
JCI Insight
April 2024
Department of Cell Biology and Molecular Medicine, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.
Duchenne muscular dystrophy (DMD) is a progressive muscle-wasting disease associated with cardiomyopathy. DMD cardiomyopathy is characterized by abnormal intracellular Ca2+ homeostasis and mitochondrial dysfunction. We used dystrophin and utrophin double-knockout (mdx:utrn-/-) mice in a sarcolipin (SLN) heterozygous-knockout (sln+/-) background to examine the effect of SLN reduction on mitochondrial function in the dystrophic myocardium.
View Article and Find Full Text PDFA Protocol for Simultaneous In Vivo Imaging of Cardiac and Neuroinflammation in Dystrophin-Deficient MDX Mice Using [F]FEPPA PET.
Int J Mol Sci
April 2023
Department of Medical Biophysics, Western University, London, ON N6A 3K7, Canada.
Article Synopsis
- Duchenne muscular dystrophy (DMD) is a serious neuromuscular disorder caused by the loss of dystrophin, leading to severe muscle degeneration and premature death, often from heart or respiratory failure.
- Innovative treatments have improved life expectancy for DMD patients but have also resulted in increased late-onset heart failure and cognitive decline, necessitating better assessment methods of related heart and brain issues.
- The study introduces a TSPO-PET imaging protocol to investigate inflammation in the hearts and brains of a dystrophin-deficient mouse model, showing significant increased activity in these areas, which could help evaluate the effects of neuroinflammation alongside cardiac issues in DMD.
Pharmacological TRPC6 inhibition improves survival and muscle function in mice with Duchenne muscular dystrophy.
JCI Insight
October 2022
Department of Cardiology.
Gene mutations causing loss of dystrophin result in the severe muscle disease known as Duchenne muscular dystrophy (DMD). Despite efforts at genetic repair, DMD therapy remains largely palliative. Loss of dystrophin destabilizes the sarcolemmal membrane, inducing mechanosensitive cation channels to increase calcium entry and promote cell damage and, eventually, muscle dysfunction.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!